EZH2 and neoplasm: Our in vivo findings are consistent with previous studies demonstrating that cells with high EZH2 expressions have an advantage in metastasizing, while EZH2 KO 4T1 tumor-bearing mice have significantly longer survival and decreased occurrence of metastatic colonies [24].